Tobramycin 40mg/ml Injection / Nebcin Injection 40mg/ml
Consideration should be given to official guidance on the appropriate use of antibacterial agents. Tobramycin Injection is indicated for the treatment of the following infections caused by susceptible micro-organisms: Central nervous system infections, including meningitis, septicaemia and neonatal sepsis Gastro-intestinal infections, including peritonitis, and other significant infections such as complicated and recurrent urinary tract infections, including pyelonephritis and cystitis Lower respiratory tract infections, including pneumonia, bronchopneumonia and acute bronchitis Skin, bone and soft tissue infections, including burns Tobramycin Injection may be considered in serious staphylococcal infections for which penicillin or other less potentially toxic drugs are contra-indicated and when bacterial susceptibility testing and clinical judgement indicate its use. See section 5.1 for species clinical breakpoints and prevalence of resistance of commonly susceptible bacterial species.